KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Change in Account Payables (2016 - 2025)

Vertex Pharmaceuticals has reported Change in Account Payables over the past 17 years, most recently at $38.3 million for Q4 2025.

  • Quarterly results put Change in Account Payables at $38.3 million for Q4 2025, up 355.95% from a year ago — trailing twelve months through Dec 2025 was $36.8 million (down 25.66% YoY), and the annual figure for FY2025 was $36.8 million, down 25.66%.
  • Change in Account Payables for Q4 2025 was $38.3 million at Vertex Pharmaceuticals, up from -$35.3 million in the prior quarter.
  • Over the last five years, Change in Account Payables for VRTX hit a ceiling of $159.9 million in Q4 2022 and a floor of -$69.9 million in Q3 2022.
  • Median Change in Account Payables over the past 5 years was $8.0 million (2024), compared with a mean of $14.4 million.
  • Biggest five-year swings in Change in Account Payables: plummeted 3425.24% in 2021 and later surged 26100.0% in 2025.
  • Vertex Pharmaceuticals' Change in Account Payables stood at $53.9 million in 2021, then skyrocketed by 196.66% to $159.9 million in 2022, then crashed by 119.89% to -$31.8 million in 2023, then soared by 126.42% to $8.4 million in 2024, then surged by 355.95% to $38.3 million in 2025.
  • The last three reported values for Change in Account Payables were $38.3 million (Q4 2025), -$35.3 million (Q3 2025), and $7.6 million (Q2 2025) per Business Quant data.